PENNSAUKEN, N.J., Jan. 12, 2021 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (NASDAQ-JJSF) announced today that its conference call to discuss its first quarter 2021 results is scheduled for Tuesday Ja
PENNSAUKEN, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (NASDAQ-JJSF) announced today that its Board of Directors has declared a regular quarterly cash dividend of $.575 per share
J & J Snack Foods is a very long-term oriented food manufacturing company. The company has negative net debt, which reduces the chances of bankruptcy to practically zero.
I was optimistic with my dividend growth predictions for the last two weeks of November. Notably, Sysco held their dividend steady and Tyson Foods – from which I had expected a double digit boost �
J&J put up decent financial figures in fiscal year 2020. The company has no long-term debt and plenty of cash.
J&J Snack Foods' (JJSF) CEO Gerry Shreiber on Q4 2020 Results - Earnings Call Transcript
J & J Snack Foods Corp. (JJSF) CEO Gerald Shreiber on Q4 2020 Results - Quick Version Earnings Call Transcript

Sales and Earnings Reported by J & J Snack Foods

04:00pm, Thursday, 05'th Nov 2020
PENNSAUKEN, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (NASDAQ-JJSF) today announced sales and earnings for its fourth quarter and year ended September 26, 2020.
PENNSAUKEN, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) --  J & J Snack Foods Corp. (NASDAQ-JJSF) announced today that its conference call to discuss its fourth quarter 2020 results is scheduled for Friday
Pfizer Inc PFE.N and Johnson & Johnson JNJ.N are seeking input from a US Food and Drug Administration advisory committee on retaining and attracting v
In its guidance on EUAs for vaccines, the FDA said earlier in October that a drugmaker should continue to collect data in any ongoing trials for as long as feasible, even after getting an authorizatio
AHF Demands Full Transparency as J&J and FDA Balk at Sharing COVID VAX Trial Info
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an ad
The mRNA coronavirus vaccine being developed by Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) is unlikely to become available under emergency use...
Pauses to clinical trials are not uncommon, and the delays should reassure the public that the systems in place intended to protect volunteers are working.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE